Actively Recruiting

Phase Not Applicable
Age: 18Years - 99Years
All Genders
Healthy Volunteers
NCT06639009

Effect of Laser Photobiomodulation in Improving Mouth Opening in Oral Submucous Fibrosis

Led by Dr. Shalini Gupta · Updated on 2024-10-15

315

Participants Needed

1

Research Sites

173 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This a patient and outcome assessor blinded, multiple arm, randomized placebo controlled clinical trial. The goal of the study is to study the adjunctive effect of 940nm laser photobiomodulation therapy (PBMT) in precancerous condition like moderate Oral submucous Fibrosis in increasing the mouth opening. It will also assess the the effect of PBMT on oral burning sensation cheek flexibility, electromyography of bilateral masseter muscle, inflammatory and fibrogenic cytokines and oral health quality of life at baseline and after 1 and 3 months of PBMT. Adult subjects fulfilling the selection criteria will be prospectively recruited after ethical clearance and informed written consent. They will be randomized into 3 groups in 1:1 :1 distribution The three groups are as follows: Group A: Photobiomodulation therapy given intraorally on bilateral buccal mucosa and extraorally (sham) with conventional non-invasive management. Group B: Photobiomodulation therapy given intraorally (bilateral buccal mucosa) and extraorally (bilateral masseter muscle) with conventional non-invasive management. Group C: Sham (Use of laser handpiece with only red guide light and without using the foot pedal which activates the laser)Photobiomodulation therapy(Placebo) (Intraoral and Extraoral) with conventional non-invasive management. The conventional non invasive management in Oral submucous fibrosis which all the groups will receive are as follows: Brief behavioral Tobacco, areca nut and alcohol habit cessation counseling as per WHO 5As and 5Rs technique at baseline and each follow up. Oral prophylaxis Removal of oral irritational factors like sharp teeth, appliances or prosthesis, impacted buccoverted third molars, parafunctional habits Oral hygiene maintenance instructions Oral physiotherapy(Mouth opening and cheek ballooning exercises) Control of systemic conditions (Anemia, Diabetes, hypertension, thyroid disorders) by specialist referral Removal of all predisposing factors for oral candida infection Advocacy for safe sexual practices Nutrition and diet counseling( seasonal and regional food rich in nutrients, vitamins, antioxidants avoidance of spicy /sour/ hot foods and drinks) Regular surveillance for malignant transformation All the outcome parameters will be assessed at baseline and 1 and 3 months after PBMT.

CONDITIONS

Official Title

Effect of Laser Photobiomodulation in Improving Mouth Opening in Oral Submucous Fibrosis

Who Can Participate

Age: 18Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects with symptomatic bilateral moderate Oral Submucous Fibrosis aged 18 years or older
  • Subjects who have not received any medical, surgical, or physical treatment for OSMF within the last three months
  • Subjects willing to participate in the study
Not Eligible

You will not qualify if you...

  • Subjects with any other oral potentially malignant disorders such as leukoplakia or oral lichen planus
  • Subjects with previous biopsy showing dysplasia or suspicious lesions requiring biopsy
  • Subjects with current or past history of any malignancies
  • Subjects with developmental disorders, cranio-maxillomandibular bony pathologies, trauma, or infections causing trismus
  • Subjects with uncontrolled systemic diseases or psychiatric disorders
  • Subjects with open wounds, scars, tattoos, or pathological skin lesions in the laser treatment area
  • Subjects unwilling to shave facial hair for electromyography
  • Subjects with autoimmune diseases like scleroderma, dermatomyositis, oral vesiculobullous diseases, or Behçet's disease
  • Subjects who have used corticosteroids, immunosuppressive, anti-inflammatory, or immune-modulating medications within the past six months
  • Subjects with temporomandibular joint disorders, cervical spondylosis, muscle dystrophy, or neuromuscular disorders
  • Pregnant individuals

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

All India Institute of Medical Sciences

New Delhi, National Capital Territory of Delhi, India, 110029

Actively Recruiting

Loading map...

Research Team

S

Shalini Gupta, MDS, FDSRCS(Erin)

CONTACT

S

Savita Yadav, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here